Press Releases
Please, enter cell line, author or any other phrase or word you would like to search for.
Options Exercised II
Phase Holographic Imaging (PHI) has two option programs, both with a final subscription date of October 24, 2017. The programs, directed to board members and advisors of the Company, were implemented as the Company was listed at AktieTorget.
Options Exercised I
Phase Holographic Imaging (PHI) has two option programs, both with a final subscription date of October 24, 2017. The programs, directed to board members and advisors of the Company, were implemented as the Company was listed at AktieTorget.
Novel HoloMonitor based research to be presented at cancer research annual meeting
Using HoloMonitor® technology from PHI the scientists have been able to follow and measure important dynamics of cancer cells in ways not possible with conventional methods, which has led to the novel research results.
Japan´s foremost medical institute purchases multiple HoloMonitor instruments
Japan’s foremost medical research institute, The Institute of Medical Science at University of Tokyo, recently purchased two HoloMonitor M4. Together with RIKEN and Kyoto University, the institute spearheads Japan’s national effort to become the undisputed leader of regenerative medicine in the world.
EU grants 2.1 million euro to Phase Holographic Imaging and Malmö University with partners for joint cancer research
The European Commission has appointed Phase Holographic Imaging,Bundesanstalt für Material-forschung und Prüfung (Germany’s federal technology research institute), Malmö, Umeå, Copenhagen and Turku University to develop improved methods for clinically diagnosing cancer.
American association of cancer research highlights article published by PHI collaborators
In the October issue of Molecular Cancer Therapeutics the American Association of Cancer Research (AACR) highlights the novel nanomedicine against ovarian cancer developed by scientists from the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University.
Lab of Nobel Price winner purchases HoloMonitor
The Department of Optical Nanoscopy (Prof. Stefan W. Hell) at the German Cancer Research Center (DKFZ) in Heidelberg recently ordered a motorized HoloMonitor M4. Professor Hell was awarded the Nobel Prize in Chemistry in 2014 for his pioneering work in the field of super-resolution fluorescence microscopy.
PHI receives significant order
HoloMonitor technology facilitates cancer research at Florida International University
Nature publishes new HoloMonitor article, PHI achieves 50 publications
Researchers at Chinese Academy of Sciences have used HoloMonitor®technology from PHI to investigate cell behavior when Earth’s magnetic field is eliminated. The findings were recently published in Scientific Reports – an online journal published by Nature Publishing Group.